| Natural products for drug discovery in the 21st century: innovations for novel drug discovery NE Thomford, DA Senthebane, A Rowe, D Munro, P Seele, A Maroyi, ... International journal of molecular sciences 19 (6), 1578, 2018 | 1047 | 2018 |
| The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer DA Senthebane, A Rowe, NE Thomford, H Shipanga, D Munro, ... International journal of molecular sciences 18 (7), 1586, 2017 | 402 | 2017 |
| Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine K Dzobo, NE Thomford, DA Senthebane, H Shipanga, A Rowe, ... Stem cells international 2018 (1), 2495848, 2018 | 387 | 2018 |
| The role of tumor microenvironment in chemoresistance: 3D extracellular matrices as accomplices DA Senthebane, T Jonker, A Rowe, NE Thomford, D Munro, C Dandara, ... International journal of molecular sciences 19 (10), 2861, 2018 | 125 | 2018 |
| Advances in therapeutic targeting of cancer stem cells within the tumor microenvironment: an updated review K Dzobo, DA Senthebane, C Ganz, NE Thomford, A Wonkam, C Dandara Cells 9 (8), 1896, 2020 | 99 | 2020 |
| Cancer stem cell hypothesis for therapeutic innovation in clinical oncology? Taking the root out, not chopping the leaf K Dzobo, DA Senthebane, A Rowe, NE Thomford, LM Mwapagha, ... Omics: a journal of integrative biology 20 (12), 681-691, 2016 | 69 | 2016 |
| The tumor microenvironment in tumorigenesis and therapy resistance revisited K Dzobo, DA Senthebane, C Dandara Cancers 15 (2), 376, 2023 | 64 | 2023 |
| Not everyone fits the mold: intratumor and intertumor heterogeneity and innovative cancer drug design and development K Dzobo, DA Senthebane, NE Thomford, A Rowe, C Dandara, MI Parker Omics: a journal of integrative biology 22 (1), 17-34, 2018 | 54 | 2018 |
| Three-dimensional organoids in Cancer research: the search for the holy grail of preclinical Cancer modeling K Dzobo, A Rowe, DA Senthebane, MAM AlMazyadi, V Patten, MI Parker Omics: a journal of integrative biology 22 (12), 733-748, 2018 | 41 | 2018 |
| Targeting the versatile Wnt/β-catenin pathway in cancer biology and therapeutics: from concept to actionable strategy K Dzobo, NE Thomford, DA Senthebane Omics: a journal of integrative biology 23 (11), 517-538, 2019 | 27 | 2019 |
| Chemoresistance to cancer treatment: Benzo-α-pyrene as friend or foe? K Dzobo, N Hassen, DA Senthebane, NE Thomford, A Rowe, H Shipanga, ... Molecules 23 (4), 930, 2018 | 21 | 2018 |
| Cancer stem cell markers in relation to patient survival outcomes: lessons for integrative diagnostics and next-generation anticancer drug development K Dzobo, C Ganz, NE Thomford, DA Senthebane Omics: a journal of integrative biology 25 (2), 81-92, 2021 | 19 | 2021 |
| The significance of Cancer stem cell markers’ gene expression and Relevance for Survival Outcomes K Dzobo, D Senthebane, C Ganz, N Thomford Preprints, 2020 | 5 | 2020 |
| Single-cell omics: deciphering tumor clonal architecture K Dzobo, NE Thomford, A Rowe, DA Senthebane, C Dandara Single-Cell Omics, 61-97, 2019 | 5 | 2019 |
| The future of tissue engineering and Regenerative Medicine in Africa K Dzobo, DA Senthebane, M Pillay, C Ssemakalu, N Mkhumbeni, ... Tissue Engineering Part A 23 (19-20), 1023-1025, 2017 | 5 | 2017 |
| The role of the tumour microenvironment components in cancer cell behaviour and drug response DA Senthebane | | 2022 |
| Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An updated Review DA Senthebane, C Ganz, NE Thomford, K Dzobo Preprints, 2020 | | 2020 |
